ישראל - עברית - Ministry of Health

medison pharma ltd - diroximel fumarate - diroximel fumarate 231 mg

ישראל - עברית - Ministry of Health

medison pharma ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 30 mcg / 0.5 ml - interferon beta-1a - interferon beta-1a - treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 1000 iu - coagulation factor ix

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 2000 iu - coagulation factor ix

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 3000 iu - coagulation factor ix

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 500 iu - coagulation factor ix

ישראל - עברית - Ministry of Health

medison pharma ltd - interferon beta 1a 30 mcg/vial - powder for solution for injection - interferon beta-1a - avonex is indicated for the treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. avonex is also indicated for the treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.

ישראל - עברית - Ministry of Health

medison pharma ltd - fampridine - טבליות בשחרור ממושך - fampridine 10 mg - fampridine - fampridine - fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7)

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate